-
transmission, and predicting public health outcomes using quantitative microbial risk assessment. Lab members conduct field research in Mozambique and Indiana, as well as wet lab work in Bloomington, Indiana. We
-
modifiers. We study maternal obesity — a rapidly rising but modifiable CHD risk factor — and its convergence with non-canonical WNT/Planar Cell Polarity signaling. Using a clinically relevant high-fat-diet
-
Alzheimer’s disease pathogenesis and neurodegeneration. Ongoing projects investigate microglial signaling pathways, neuroimmune interactions, genetic risk factors, and therapeutic targets using state-of-the-art
-
the chance to help set the agenda for our new research center. Postdoctoral fellows will have the opportunity to organize meetings and workshops at the Center as well as to propose new Center initiatives. We
-
discovery to identify children at risk for developing kidney disease and to guide personalized treatment strategies. By leveraging advanced technologies in genomics, proteomics, and metabolomics, our goal is